July 7, 2021 — Annalise.ai has launched its comprehensive chest X-ray AI solution Annalise CXR, which detects 124 clinical findings and is a decision support tool for radiologists and clinicians. The company was originally formed as a joint venture between Australian healthcare technology company Harrison.ai and one of the world’s largest radiology companies, I–MED Radiology Network


The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment practices.


July 7, 2021 — Amid the COVID-19 crisis, the global market for single photon emission computed tomography (SPECT) estimated at $1.7 billion in the year 2020, is projected to reach a revised size of $2.7 billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027.


I have had the privilege of watching our industry grow and evolve over the past 20 years. My introduction to the imaging space was assisting in the transformation of a hospital system from film-driven to PACS-driven imaging workflow.



The unprecedented impacts and consequential social, economic and humanitarian needs introduced or exacerbated by COVID-19 are driving the rapid development and adoption of new digital technologies and at scale.



There is a lot of talk about health disparities between the insured vs. uninsured, low-income vs. higher-income, rural vs. urban residents, and developed vs. developing world. In developed countries there also is growing tsunami of elderly patients that is growing as baby boomers retire and require more medical care.



It is well established that there are racial disparities in healthcare that can have devastating implications for patient outcomes, and this has been shown to be particularly true for



The challenges faced by hospitals during the COVID-19 pandemic have severely impacted cancer care.


Subscribe Now